Demographic features, presentation, and outcome EBV+ THRLBCL-like vs THRLBCL
| Characteristics . | THRLBCL–like . | THRLBCL . | P* . |
|---|---|---|---|
| Total cases | 36 | 40 | |
| Age median (range) | 24 (4-45) | 49 (21-87) | |
| Male/female | 32/4 (8:1) | 29/11 | .089 |
| LDH, n | 32 | 40 | .33 |
| Normal, n (%) | 10 (31) | 18 (45) | |
| Elevated, n (%) | 22 (69) | 22 (55) | |
| Splenomegaly, n | 35 | 40 | .065 |
| Present, n (%) | 13 (37) | 24 (60) | |
| Absent, n (%) | 22 (63) | 16 (40) | |
| Bone marrow involvement, n | 32 | 40 | .23 |
| Present, n (%) | 9 (28) | 17 (43) | |
| Absent, n (%) | 23 (72) | 23 (57) | |
| Clinical stage, n | 30 | 40 | .056 |
| I + II, n (%) | 12 (40) | 7 (18) | |
| III + IV, n (%) | 18 (60) | 33 (82) | |
| IPI score, n | 15 | 40 | 1.00 |
| L + LI (0-2), n (%) | 9 (60) | 24 (60) | |
| HI + H (3-4), n (%) | 6 (40) | 16 (40) | |
| Outcome, n | 31 | 40 | |
| Alive, NoD/CR, n (%) | 27 (87) | 12 (30) | |
| Alive, AwD, n (%) | 3 (10) | 4 (10) | |
| DOD, n (%) | 1 (3) | 22 (55) | |
| DUC, n (%) | 0 (0) | 2 (5) | |
| Median (range) follow-up, mo | 24 (4-96) | 19.5 (0-122) |
| Characteristics . | THRLBCL–like . | THRLBCL . | P* . |
|---|---|---|---|
| Total cases | 36 | 40 | |
| Age median (range) | 24 (4-45) | 49 (21-87) | |
| Male/female | 32/4 (8:1) | 29/11 | .089 |
| LDH, n | 32 | 40 | .33 |
| Normal, n (%) | 10 (31) | 18 (45) | |
| Elevated, n (%) | 22 (69) | 22 (55) | |
| Splenomegaly, n | 35 | 40 | .065 |
| Present, n (%) | 13 (37) | 24 (60) | |
| Absent, n (%) | 22 (63) | 16 (40) | |
| Bone marrow involvement, n | 32 | 40 | .23 |
| Present, n (%) | 9 (28) | 17 (43) | |
| Absent, n (%) | 23 (72) | 23 (57) | |
| Clinical stage, n | 30 | 40 | .056 |
| I + II, n (%) | 12 (40) | 7 (18) | |
| III + IV, n (%) | 18 (60) | 33 (82) | |
| IPI score, n | 15 | 40 | 1.00 |
| L + LI (0-2), n (%) | 9 (60) | 24 (60) | |
| HI + H (3-4), n (%) | 6 (40) | 16 (40) | |
| Outcome, n | 31 | 40 | |
| Alive, NoD/CR, n (%) | 27 (87) | 12 (30) | |
| Alive, AwD, n (%) | 3 (10) | 4 (10) | |
| DOD, n (%) | 1 (3) | 22 (55) | |
| DUC, n (%) | 0 (0) | 2 (5) | |
| Median (range) follow-up, mo | 24 (4-96) | 19.5 (0-122) |
DUC, died of unrelated causes.
Fisher's exact test.